Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced preparation method for TRPA1 antagonists offering high yield and scalability. Discover cost reduction in API manufacturing with our optimized synthetic routes.
Novel resolution method ensures high purity acetate salt stability for scalable API manufacturing and significant cost reduction in production.
Patent CN107488138B details a high-yield dithiolane-protected route for ezetimibe intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Patent CN1054980A details chiral synthesis of 3-amino-4-methylpyrrolidine derivatives from natural amino acids, enabling high-purity quinolone antibiotic production with improved supply chain stability.
Patent CN101848905A details a novel enantioselective route for (S)-pregabalin using D-mannitol, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel preparation method for oxazolidinone intermediates via CN108430999B. Offers superior chirality control, cost reduction, and scalable manufacturing for pharmaceutical applications.
Novel synthesis of (S)/(R)-midpacamide using chiral amino acids. Solves racemization, >99% purity. Reliable supply for pharma R&D.
Patent CN101805323B details a safer, scalable route for Doranidazole intermediates using diethyl tartrate, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN1189458C details a chiral pool synthesis of key Substance P antagonists. Discover cost-effective manufacturing and supply chain advantages.
Novel method for avibactam intermediate using L-camphorsulfonamide. High yield, stereoselective route for reliable pharmaceutical intermediate supplier.
Patent CN109293508B reveals a cost-effective synthesis of entecavir intermediates using (+)-Coreylactone diol, offering superior optical purity and scalable manufacturing for antiviral drugs.
Novel synthetic method for penem antibiotic intermediate 4AA using L-threonine. High purity 99.34%, scalable process, cost-effective manufacturing solution.
Patent CN1978442A details a novel mannitol-based route for Nepyrrolol HCl, offering improved purity and scalability for reliable pharmaceutical intermediate suppliers.
Patent CN102603591B details a novel route for Vernakalant intermediates. Offers mild conditions, high optical purity, and scalable supply chain solutions for global procurement.
Patent CN107778192A details a resolution-free route for high-purity chiral amino acids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel low-cost route for Sitagliptin intermediates via chiral resolution. Reduces catalyst costs and simplifies scale-up for API manufacturing.
Patent CN104496843B details a low-cost ubenimex synthesis route avoiding toxic resolving agents, offering significant supply chain and purity advantages for pharmaceutical manufacturers.
Novel patent CN107129501B details cost-effective Sitagliptin synthesis using L-Aspartic acid, offering supply chain stability and high purity for pharmaceutical partners.
Patent CN103435532A details a low-cost synthesis of Boceprevir intermediates. Discover how this novel route eliminates precious metal catalysts for superior supply chain reliability.
Novel patent CN103936644A offers high-purity Zofenopril Calcium with improved chiral control and cost-effective manufacturing for global supply chains.